Why Novo Nordisk Stock Fell Even After Wegovy Pill Hit 3 Million Prescriptions
Novo Nordisk’s Copenhagen-listed B shares fell 4.2% to DKK 272.00 after Monday’s session, underperforming a 0.9% drop in the OMX Copenhagen 25, even as the Danish drugmaker reported another strong demand marker for its Wegovy pill. Its U.S.-listed shares were at $41.02, down about 4.6%.
